CINCOR PHARMA INC's ticker is and the CUSIP is 17240Y109. A total of 1 filers reported holding CINCOR PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $16,124 | – | 1,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 4,937,646 | $60,683,669 | 16.31% |
| Sofinnova Investments, Inc. | 6,073,949 | $74,648,833 | 4.43% |
| Omega Fund Management, LLC | 560,985 | $7,853,790 | 2.65% |
| GREAT POINT PARTNERS LLC | 1,019,153 | $12,525,390 | 2.46% |
| venBio Partners LLC | 383,390 | $4,711,863 | 1.46% |
| Cheyne Capital Management (UK) LLP | 67,557 | $830,276 | 1.45% |
| SPHERA FUNDS MANAGEMENT LTD. | 529,640 | $6,509,276 | 1.40% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 395,382 | $4,859,245 | 1.39% |
| Perceptive Advisors | 2,576,325 | $31,663,034 | 0.89% |
| AlphaCentric Advisors LLC | 70,000 | $860,300 | 0.85% |